CHD/Prevention

Top Story

High-risk patients unable to take PCSK9 inhibitors have poor outcomes

High-risk patients unable to take PCSK9 inhibitors have poor outcomes
July 23, 2019
Meeting News

SGLT2 inhibitors may have great potential in reducing HF in diabetes

July 23, 2019
SAN ANTONIO — Several studies on SGLT2 inhibitors have shown that they may be able to reduce HF in patients with diabetes, according to a presentation at the…
In the Journals

Moderate calorie restriction reduces CV risk in normal weight, healthy adults

July 23, 2019
Healthy, young and middle-aged adults without obesity assigned to 2 years of moderate calorie restriction substantially lowered their cardiometabolic risks with…
Meeting NewsVideo

VIDEO: Health economics 101 for the cardiologist

July 22, 2019
SAN ANTONIO — In this video exclusive, Seth J. Baum, MD, FACC, FACPM, FAHA, FNLA, FASPC, chief medical officer of Excel Medical Clinical Trials, clinical…
More Headlines »
CME

Individualizing the Treatment of Type 2 Diabetes With a Focus on Cardiovascular Outcomes

This activity is supported by an educational grant from the Merck/Pfizer Alliance.

Emerging clinical evidence regarding the impact of hyperglycemia on cardiovascular outcomes warrants that physicians…
More »
Video
Meeting News

VIDEO: Achieving very low LDL levels may benefit patients

June 9, 2019
More »
Video
Meeting News

VIDEO: Heart in Diabetes aims to address ‘avalanche of data’ on diabetes, CVD

July 16, 2019
More »